Clinical Study

The Use of Dexamethasone in Bacterial Meningitis in Children and Adults: A Retrospective Analysis

Table 1

Prognostic factors for unfavourable versus favourable outcome after 8 weeks.

Unfavourable ( š‘› = 1 7 )Favourable ( š‘› = 4 9 )Odds ratio (95% CI)*

Age (yr)ā€”mean Ā± SD21 Ā± 3020 Ā± 32ā€”
Malesā€”%6551ā€”
Duration symptoms before admission (hr)ā€”mean Ā± SD45 Ā± 4534 Ā± 41ā€”
Duration symptoms before admission <24ā€‰hrsā€”no./tot. no. (%)10/17 (59)36/480.48 (0.15ā€“1.53)
Received dexamethasoneā€”no./tot. no. (%)11/17 (65)33/49 (67)0.89 (0.18ā€“2.84)
Received AB in last 48ā€‰hrā€”no./tot. no. (%)4/17 (24)9/48 (19)1.33 (0.35ā€“5.06)
Coexisting conditionsā€”no./tot. no. (%)
ā€ƒOtitis/sinusitis2/17 (12)15/49 (31)0.30 (0.061ā€“1.49)
ā€ƒPneumoniae3/17 (18)4/49 (8)2.41 (0.48ā€“12.09)
ā€ƒImmunocompromise4/17 (24)3/49 (6)4,72 (0,96ā€“23,8)
Convulsions on admissionā€”no./tot. no. (%)7/17 (41)6/49 (12)5,0 (1,4ā€“18,2)
Findings on admissionā€”no./tot. no. (%)
ā€ƒNormal consciousness2/17 (12)31/49 (63)0,07 (0,02ā€“0,38)
ā€ƒGCS score < 84/10 (40)2/40 (5)12.67 (1.89ā€“84.97)
ā€ƒFocal neurological signs5/17 (29)2/49 (4)9,8 (1,69ā€“56,8)
ā€ƒTemperature > 38Ā°C13/17 (76)34/48 (71)1.34 (0.37ā€“44.82)
ā€ƒTriad (neck stiffness, fever, and altered mental status)4/11 (36)10/35 (28)1.43 (0.34ā€“5.97)
ā€ƒPetechiae1/17 (6)21/49 (43)0,08 (0,01ā€“0,68)
CSF cultureā€”no./tot. no. (%)
ā€ƒS. pneumonia12/17 (70)15/49 (31)5,44 (1,62ā€“18,2)
ā€ƒN. meningitidis3/17 (18)17/49 (35)0,4 (0,102ā€“1,60)
ā€ƒOther bacteria1/17 (6)8/49 (16)0.32 (0.037ā€“2.77)
ā€ƒNegative culture1/17 (6)9/49 (18)0.28 (0.032ā€“2.37)
CSF parameters
ā€ƒPositive bacterial cultureā€”no./tot. no. (%)16/16 (100)38/49 (78)ā€”
ā€ƒWBC (/mm3)ā€”mean Ā± SD3401 Ā± 72116057 Ā± 8156ā€”
ā€ƒWBC < 1000/mm3ā€”no./tot. no. (%)10/13 (77)15/49 (31)7,6 (1,82ā€“31,4)
ā€ƒProteins (mg/dL)ā€”mean Ā± SD558 Ā± 557305 Ā± 263ā€”
ā€ƒProteins > 500ā€‰mg/dLā€”no/tot no (%)6/13 (46)12/49 (24)2,64 (0,74ā€“9,39)
ā€ƒGlucose (mg/dL)ā€”mean Ā± SD18,5 Ā± 21,835,6 Ā± 25,1ā€”
ā€ƒGlucose < 20ā€‰mg/dLā€”no/tot no (%)11/13 (85)20/49 (41)7,98 (1,59ā€“39,9)
ā€ƒGlucose CSF/serum ratio (%)ā€”mean Ā± SD16 Ā± 1428 Ā± 20ā€”
ā€ƒLactate (mmol/L)ā€”mean Ā± SD12,3 Ā± 4,98,0 Ā± 5,0ā€”
ā€ƒLactate > 10ā€‰mmol/Lā€”no./tot. no. (%)7/9 (78)15/44 (34)6,77 (1,25ā€“36,7)
Positive blood culture, no./tot. no. (%)9/16 (56)22/48 (56)1.52 (0.49ā€“4.75)
Blood parameters
ā€ƒHb** (g/dL)ā€”mean Ā± SD10,8 Ā± 2,412,0 Ā± 1,9ā€”
ā€ƒPlatelets (Ɨ103/mm3)ā€”mean Ā± SD269 Ā± 143280 Ā± 148ā€”
ā€ƒCRP*** (mg/L)ā€”mean Ā± SD258 Ā± 119176 Ā± 128ā€”
ā€ƒCRP > 200ā€‰mg/Lā€”no./tot. no. (%)12/17 (70)19/49 (39)3,78 (1,15ā€“12,5)
ā€ƒHyponatremia** in first 72uā€”no./tot. no. (%)4/17 (24)2/49 (4)7,23 (1,19ā€“43,9)
Referred from an other hospitalā€”no./tot. no. (%)10/17 (59)9/49 (18)6,35 (1,9ā€“21,2)

*CI = confidence interval, **Hb = haemoglobin, ***CRP = C-reactive protein.